Empire Life Investments’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36.8M Sell
144,822
-7,004
-5% -$1.63M 2.05% 12
2026
Q1
$37.1M Sell
151,826
-7,406
-5% -$1.73M 2.25% 10
2025
Q4
$33M Sell
159,232
-15,580
-9% -$3.08M 1.86% 14
2025
Q3
$32.4M Buy
174,812
+2,081
+1% +$357K 1.9% 13
2025
Q2
$26.4M Sell
172,731
-10,544
-6% -$1.62M 1.68% 17
2025
Q1
$30.4M Sell
183,275
-9,647
-5% -$1.51M 1.98% 12
2024
Q4
$27.9M Sell
192,922
-15,956
-8% -$2.47M 1.75% 18
2024
Q3
$33.9M Buy
208,878
+347
+0.2% +$55.3K 2.06% 15
2024
Q2
$30.5M Sell
208,531
-9,769
-4% -$1.45M 1.92% 15
2024
Q1
$34.5M Sell
218,300
-10,780
-5% -$1.72M 2.12% 16
2023
Q4
$35.9M Sell
229,080
-6,683
-3% -$1.02M 2.32% 15
2023
Q3
$36.7M Sell
235,763
-28,757
-11% -$4.75M 2.69% 10
2023
Q2
$43.8M Sell
264,520
-9,193
-3% -$1.48M 2.99% 8
2023
Q1
$42.4M Buy
273,713
+14,051
+5% +$2.27M 3.02% 7
2022
Q4
$45.9M Sell
259,662
-10,508
-4% -$1.81M 3.15% 7
2022
Q3
$44.1M Buy
270,170
+2,459
+0.9% +$416K 3.36% 5
2022
Q2
$47.5M Buy
267,711
+2,058
+0.8% +$367K 3.43% 5
2022
Q1
$47.1M Sell
265,653
-4,484
-2% -$763K 3.02% 7
2021
Q4
$46.2M Sell
270,137
-2,037
-0.7% -$333K 2.82% 8
2021
Q3
$44M Sell
272,174
-58
-0% -$9.89K 2.88% 8
2021
Q2
$44.8M Sell
272,232
-3,406
-1% -$564K 2.88% 8
2021
Q1
$45.3M Sell
275,638
-18,978
-6% -$3.07M 3.11% 7
2020
Q4
$46.4M Buy
294,616
+11,061
+4% +$1.63M 3.28% 6
2020
Q3
$42.2M Sell
283,555
-9,055
-3% -$1.34M 3.39% 8
2020
Q2
$41.1M Sell
292,610
-10,331
-3% -$1.51M 3.62% 7
2020
Q1
$39.7M Sell
302,941
-50,931
-14% -$7.23M 3.64% 4
2019
Q4
$51.6M Buy
353,872
+144,620
+69% +$19.6M 3.93% 3
2019
Q3
$27.1M Sell
209,252
-25,386
-11% -$3.34M 2.27% 19
2019
Q2
$32.7M Buy
234,638
+4,141
+2% +$573K 2.64% 9
2019
Q1
$32.2M Buy
230,497
+10,520
+5% +$1.41M 2.7% 7
2018
Q4
$28.4M Buy
219,977
+27,939
+15% +$3.9M 2.55% 7
2018
Q3
$26.5M Sell
192,038
-12,725
-6% -$1.69M 2.02% 13
2018
Q2
$24.8M Buy
204,763
+970
+0.5% +$121K 1.79% 17
2018
Q1
$26.1M Buy
203,793
+4,433
+2% +$599K 1.85% 17
2017
Q4
$27.9M Buy
199,360
+196
+0.1% +$27.3K 2.15% 13
2017
Q3
$25.9M Sell
199,164
-6,099
-3% -$808K 2.09% 12
2017
Q2
$27.2M Sell
205,263
-41,209
-17% -$5.26M 2.37% 9
2017
Q1
$22.9M Sell
246,472
-30,862
-11% -$3.69M 2.23% 10
2016
Q4
$28M Buy
+277,334
New +$32M 2.27% 12

Other funds holding JNJ

Empire Life Investments's JNJ Position: Q2 2026 in Review

Empire Life Investments reduced its Johnson & Johnson (JNJ) stake by 4.6% in Q2 2026, selling an estimated $1.63M and leaving 144,822 shares worth $36.8M. The position accounts for 2.05% of the portfolio, ranked #12.

Empire Life Investments first reported a position in JNJ in Q4 2016 and has held it in 39 quarters since. The position peaked at $51.6M in Q4 2019. 2,235 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Empire Life Investments held 144,822 shares of Johnson & Johnson worth $36.8M as of Q2 2026.
  • Empire Life Investments sold 7,004 Johnson & Johnson shares in Q2 2026, an estimated $1.63M.
  • Johnson & Johnson made up 2.05% of Empire Life Investments's portfolio in Q2 2026, its #12 holding.
  • Empire Life Investments first reported a position in Johnson & Johnson in Q4 2016 and has held it in 39 quarters since.
  • Empire Life Investments's Johnson & Johnson position peaked at $51.6M in Q4 2019.
  • 2,235 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Empire Life Investments's 13F filing for Q2 2026, filed 24 Jul 2026.